Switching to single-use bioreactors can have financial and performance benefits.
Jean-François Chaubard
Advertisement
Jean-François Chaubard is a director at Viral Industrial Bulk, GSK Biologicals
Articles by Jean-François Chaubard
Advertisement
Latest Updated Articles
Disposable Bioreactors for Viral Vaccine Production: Challenges and OpportunitiesPublished: November 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
3
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
4
Achieving Real Impact Navigating the Data and Regulatory Barriers to AI Adoption in Bio/pharma
5
